BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27

• BioMidwest

  Piper Jaffray To Host 25th Annual Healthcare Conference

  November 18, 2013

   · 

  1 min read
• Business

  Arno Therapeutics Adds Steven Rubin, EVP of Opko Health, Inc., as Board Observer

  November 18, 2013

   · 

  1 min read
• Business

  Eisai Inc. Announces Partnership With NewBridge Pharmaceuticals To Market Breast Cancer Treatment Halaven® (Eribulin) Across The Middle East

  November 18, 2013

   · 

  5 min read
• Pharm Country

  Vision-Sciences, Inc. To Host One-On-Ones At Brean Capital 2013 Life Sciences Summit In NYC On November 25th

  November 18, 2013

   · 

  1 min read
• Deals

  Announcement Of A Firm Intention By CFR Pharmaceuticals To Acquire 100% Of The Issued Share Capital Of Adcock Ingram By Way Of A Scheme Of Arrangement

  November 18, 2013

   · 

  1 min read
• M&G Chemicals Launches Green Revolution In The Polyester Chain

  November 18, 2013

   · 

  5 min read
• Policy

  BioMarin Pharmaceutical Inc. Release: FDA Posts Briefing Documents For Advisory Committee Meeting Reviewing Vimizim™ For The Treatment Of Morquio A Syndrome

  November 18, 2013

   · 

  1 min read
• Drug Development

  BioCardia Release: Phase 2 TAC-HFT Trial Shows Excellent Safety Profile, Suggests Efficacy, For Transendocardial Delivery Of Two Types Of Autologous Cells For Ischemic Heart Failure

  November 18, 2013

   · 

  1 min read
• Drug Development

  First Human Data Show Promise Of Boehringer Ingelheim Corporation’s Specific Antidote For Immediate, Complete And Sustained Reversal Of Pradaxa®-Induced Anticoagulation

  November 18, 2013

   · 

  1 min read
• Lone Star Bio

  DNAtrix Has Been Named As One Of The “Top Advanced Therapies Projects To Watch” And Will Present At The Therapeutic Area Partnerships

  November 18, 2013

   · 

  1 min read